Clinical Practice Guideline - Asthma
| Topic: Asthma |
Date of Origin: April 1998 |
| Revised/Effective Date: May 2006 |
Next Review Date: May 2008 |
Recommendation Summary:
Asuris supports the asthma recommendations
on medications, monitoring and prevention issued
by the National Asthma Education and Prevention
Program (NAEPP) Expert Panel Report from the
National, Heart, Lung & Blood Institute,
National Institutes of Health.
Web Site Link:
Key Points:
All practitioners and members should be aware
of the recommendations of the NAEPP for the management
of asthma. These recommendations, presented in a table format outline medication dosing and a stepwise approach for the management of asthma.
Asuris Resources:
Washington Healthy Options and PEBB members
with asthma are eligible for participation in
the asthma disease management programs. All
other Asuris members please check your benefits
to determine eligibility for the disease management
programs.
Asthma educational materials are included on the Asuris Web site.
Guideline Adoption and Recommended
Use:
This guideline has been adopted based on nationally
recognized sources. This guideline is based on the most recent medical evidence or a consensus on clinical treatment patterns by physicians in the selected field of practice. Asuris adopts guidelines to help practitioners and members make decisions about appropriate health care for specific medical conditions. Guidelines
are not a substitute for the advice of a physician.
Benefit Determination:
Benefit determinations should be based in all
cases on the applicable contract language. To the extent that there are any conflicts between these guidelines and the contract language, the contract language will control.
Back to Index 
|
